Virology of hepatitis C virus infection. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Best Practice and Research: Clinical Gastroenterology Année : 2012

Virology of hepatitis C virus infection.

Résumé

The multiple steps of the HCV lifecycle have been recently unravelled, thanks to the development of a number of cell-free or cell culture-based model systems. The HCV lifecycle offers a very large number of potential targets of intervention for specific anti-HCV drugs, including direct-acting antiviral drugs and host-targeted agents. HCV virological tools include enzyme immunoassays (EIAs) that detect anti-HCV antibodies and detect/quantify HCV core antigen, and molecular biology-based assays that are used to detect and quantify HCV RNA and to determine the HCV genotype. Recently, point-of-care tests and alternatives to laboratory tests that require whole-blood samples have been developed to improve access to screening, diagnosis and care. Virological tools are used in clinical practice to diagnose acute and chronic HCV infection, to decide who should be treated, to select the optimal therapy and to monitor treatment responses in order to tailor treatment duration.
Fichier principal
Vignette du fichier
YBEGA-12-233Pawlotsky_revision.pdf (32 B) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-00777736 , version 1 (18-01-2013)

Identifiants

Citer

Stéphane Chevaliez, Jean-Michel Pawlotsky. Virology of hepatitis C virus infection.. Best Practice and Research: Clinical Gastroenterology, 2012, 26 (4), pp.381-9. ⟨10.1016/j.bpg.2012.09.006⟩. ⟨inserm-00777736⟩

Collections

INSERM IMRB UPEC
222 Consultations
194 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More